,city,zip,country,website,industry,sector,longBusinessSummary,companyOfficers,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,Darmstadt,64295,Germany,https://cytotools.de,Biotechnology,Healthcare,"bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany.","{'maxAge': 1, 'name': 'Dr. Mark-Andr√©  Freyberg', 'title': 'Chief Exec. Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",86400,4,1.59,1.64,1.59,1.64,1.59,1.64,1.59,1.64,0.0,1.466966,20,20,948,443,443,1.54,1.6,25600,140000,8168625,1.095,3.65,667.75323,1.8764,2.083775,0.0,0.0,EUR,6945250,0.0,5137500,0.0,0.00117,4.169,0.38138643,1672444800,1703980800,1672444800,-829836,-0.16,567.747,-8.493,GER,EQUITY,T5O.DE,T5O.DE,BIOXXMED AG  INH O.N.,bioXXmed AG,1166428800,Europe/Berlin,CEST,7200000,1.59,34.85,34.85,34.85,34.85,2.0,buy,1,1839871,0.358,-817748,0,10.691,10.998,12233,0.002,-0.025799999,-0.04225,12233,-0.799,1.0,0.0,-67.27671,EUR,
1,Darmstadt,64295,Germany,https://cytotools.de,Biotechnology,Healthcare,"bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany.","{'maxAge': 1, 'name': 'Dr. Dirk  Kaiser', 'title': 'Co-Founder & Chief Research Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",86400,4,1.59,1.64,1.59,1.64,1.59,1.64,1.59,1.64,0.0,1.466966,20,20,948,443,443,1.54,1.6,25600,140000,8168625,1.095,3.65,667.75323,1.8764,2.083775,0.0,0.0,EUR,6945250,0.0,5137500,0.0,0.00117,4.169,0.38138643,1672444800,1703980800,1672444800,-829836,-0.16,567.747,-8.493,GER,EQUITY,T5O.DE,T5O.DE,BIOXXMED AG  INH O.N.,bioXXmed AG,1166428800,Europe/Berlin,CEST,7200000,1.59,34.85,34.85,34.85,34.85,2.0,buy,1,1839871,0.358,-817748,0,10.691,10.998,12233,0.002,-0.025799999,-0.04225,12233,-0.799,1.0,0.0,-67.27671,EUR,
2,Darmstadt,64295,Germany,https://cytotools.de,Biotechnology,Healthcare,"bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany.","{'maxAge': 1, 'name': 'Dr. Bruno  Rosen', 'title': 'Member of Exec. Board', 'exercisedValue': 0, 'unexercisedValue': 0}",86400,4,1.59,1.64,1.59,1.64,1.59,1.64,1.59,1.64,0.0,1.466966,20,20,948,443,443,1.54,1.6,25600,140000,8168625,1.095,3.65,667.75323,1.8764,2.083775,0.0,0.0,EUR,6945250,0.0,5137500,0.0,0.00117,4.169,0.38138643,1672444800,1703980800,1672444800,-829836,-0.16,567.747,-8.493,GER,EQUITY,T5O.DE,T5O.DE,BIOXXMED AG  INH O.N.,bioXXmed AG,1166428800,Europe/Berlin,CEST,7200000,1.59,34.85,34.85,34.85,34.85,2.0,buy,1,1839871,0.358,-817748,0,10.691,10.998,12233,0.002,-0.025799999,-0.04225,12233,-0.799,1.0,0.0,-67.27671,EUR,
